Product NDC: | 0179-0028 |
Proprietary Name: | Stavudine |
Non Proprietary Name: | Stavudine |
Active Ingredient(s): | 40 mg/1 & nbsp; Stavudine |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0179-0028 |
Labeler Name: | KAISER FOUNDATION HOSPITALS |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078957 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100127 |
Package NDC: | 0179-0028-70 |
Package Description: | 30 CAPSULE in 1 BOX, UNIT-DOSE (0179-0028-70) |
NDC Code | 0179-0028-70 |
Proprietary Name | Stavudine |
Package Description | 30 CAPSULE in 1 BOX, UNIT-DOSE (0179-0028-70) |
Product NDC | 0179-0028 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Stavudine |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20100127 |
Marketing Category Name | ANDA |
Labeler Name | KAISER FOUNDATION HOSPITALS |
Substance Name | STAVUDINE |
Strength Number | 40 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |